APO RESEARCH · REPORT
Antipyretic Analgesics
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
Product & engineering
Understand the product.
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
Selected research
Industry Research
Antipyretic Analgesics Industry Research Report 2026
Market perspective
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
Read the full market overview
Report Scope
This report quantifies the global Antipyretic Analgesics market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antipyretic Analgesics Market by Company
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Antipyretic Analgesics Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Antipyretic Analgesics Segment by Application
Adults
Children
Antipyretic Analgesics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antipyretic Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Paracetamol
- Aspirin
- Ibuprofen
- Naproxen
- Diclofenac
- Oxaprozin
- Dexibuprofen
- Others
Applications
- Adults
- Children
Companies covered
- Mallinckrodt Pharmaceuticals
- IOL
- Anqiu Lu'an Pharmaceutical
- Novacyl
- BASF
- Anhui BBCA Pharmaceuticals
- Hubei Biocause
- Xinhua Pharm
- Granules India Limited
- Huagang Pharm
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Hebei Jingye Medical Technology
- MSPF
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antipyretic Analgesics Market Size (2021-2032)
- 2.2.2 Global Antipyretic Analgesics Sales (2021-2032)
- 2.2.3 Global Antipyretic Analgesics Market Average Price (2021-2032)
- 2.3 Antipyretic Analgesics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Paracetamol
- 2.3.3 Aspirin
- 2.3.4 Ibuprofen
- 2.3.5 Naproxen
- 2.3.6 Diclofenac
- 2.3.7 Oxaprozin
- 2.3.8 Dexibuprofen
- 2.3.9 Others
- 2.4 Antipyretic Analgesics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antipyretic Analgesics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antipyretic Analgesics Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Antipyretic Analgesics Revenue of Manufacturers (2021-2026)
- 3.4 Global Antipyretic Analgesics Average Price by Manufacturers (2021-2026)
- 3.5 Global Antipyretic Analgesics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antipyretic Analgesics, Product Type & Application
- 3.8 Global Manufacturers of Antipyretic Analgesics, Established Date
- 3.9 Global Antipyretic Analgesics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mallinckrodt Pharmaceuticals
- 4.1.1 Mallinckrodt Pharmaceuticals Company Information
- 4.1.2 Mallinckrodt Pharmaceuticals Business Overview
- 4.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
- 4.1.5 Mallinckrodt Pharmaceuticals Recent Developments
- 4.2 IOL
- 4.2.1 IOL Company Information
- 4.2.2 IOL Business Overview
- 4.2.3 IOL Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 IOL Antipyretic Analgesics Product Portfolio
- 4.2.5 IOL Recent Developments
- 4.3 Anqiu Lu'an Pharmaceutical
- 4.3.1 Anqiu Lu'an Pharmaceutical Company Information
- 4.3.2 Anqiu Lu'an Pharmaceutical Business Overview
- 4.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
- 4.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
- 4.4 Novacyl
- 4.4.1 Novacyl Company Information
- 4.4.2 Novacyl Business Overview
- 4.4.3 Novacyl Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novacyl Antipyretic Analgesics Product Portfolio
- 4.4.5 Novacyl Recent Developments
- 4.5 BASF
- 4.5.1 BASF Company Information
- 4.5.2 BASF Business Overview
- 4.5.3 BASF Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BASF Antipyretic Analgesics Product Portfolio
- 4.5.5 BASF Recent Developments
- 4.6 Anhui BBCA Pharmaceuticals
- 4.6.1 Anhui BBCA Pharmaceuticals Company Information
- 4.6.2 Anhui BBCA Pharmaceuticals Business Overview
- 4.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
- 4.6.5 Anhui BBCA Pharmaceuticals Recent Developments
- 4.7 Hubei Biocause
- 4.7.1 Hubei Biocause Company Information
- 4.7.2 Hubei Biocause Business Overview
- 4.7.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
- 4.7.5 Hubei Biocause Recent Developments
- 4.8 Xinhua Pharm
- 4.8.1 Xinhua Pharm Company Information
- 4.8.2 Xinhua Pharm Business Overview
- 4.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
- 4.8.5 Xinhua Pharm Recent Developments
- 4.9 Granules India Limited
- 4.9.1 Granules India Limited Company Information
- 4.9.2 Granules India Limited Business Overview
- 4.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
- 4.9.5 Granules India Limited Recent Developments
- 4.10 Huagang Pharm
- 4.10.1 Huagang Pharm Company Information
- 4.10.2 Huagang Pharm Business Overview
- 4.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
- 4.10.5 Huagang Pharm Recent Developments
- 4.11 Hebei Jiheng Pharmaceutical
- 4.11.1 Hebei Jiheng Pharmaceutical Company Information
- 4.11.2 Hebei Jiheng Pharmaceutical Business Overview
- 4.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
- 4.11.5 Hebei Jiheng Pharmaceutical Recent Developments
- 4.12 Zhejiang Kangle Pharmaceutical
- 4.12.1 Zhejiang Kangle Pharmaceutical Company Information
- 4.12.2 Zhejiang Kangle Pharmaceutical Business Overview
- 4.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
- 4.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
- 4.13 Hebei Jingye Medical Technology
- 4.13.1 Hebei Jingye Medical Technology Company Information
- 4.13.2 Hebei Jingye Medical Technology Business Overview
- 4.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
- 4.13.5 Hebei Jingye Medical Technology Recent Developments
- 4.14 MSPF
- 4.14.1 MSPF Company Information
- 4.14.2 MSPF Business Overview
- 4.14.3 MSPF Antipyretic Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 MSPF Antipyretic Analgesics Product Portfolio
- 4.14.5 MSPF Recent Developments
5 Global Antipyretic Analgesics Market Scenario by Region
- 5.1 Global Antipyretic Analgesics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antipyretic Analgesics Sales by Region: 2021-2032
- 5.2.1 Global Antipyretic Analgesics Sales by Region: 2021-2026
- 5.2.2 Global Antipyretic Analgesics Sales by Region: 2027-2032
- 5.3 Global Antipyretic Analgesics Revenue by Region: 2021-2032
- 5.3.1 Global Antipyretic Analgesics Revenue by Region: 2021-2026
- 5.3.2 Global Antipyretic Analgesics Revenue by Region: 2027-2032
- 5.4 North America Antipyretic Analgesics Market Facts & Figures by Country
- 5.4.1 North America Antipyretic Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antipyretic Analgesics Sales by Country (2021-2032)
- 5.4.3 North America Antipyretic Analgesics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antipyretic Analgesics Market Facts & Figures by Country
- 5.5.1 Europe Antipyretic Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antipyretic Analgesics Sales by Country (2021-2032)
- 5.5.3 Europe Antipyretic Analgesics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antipyretic Analgesics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antipyretic Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antipyretic Analgesics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antipyretic Analgesics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antipyretic Analgesics Market Facts & Figures by Country
- 5.7.1 South America Antipyretic Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antipyretic Analgesics Sales by Country (2021-2032)
- 5.7.3 South America Antipyretic Analgesics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antipyretic Analgesics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antipyretic Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antipyretic Analgesics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antipyretic Analgesics Sales by Type (2021-2032)
- 6.1.1 Global Antipyretic Analgesics Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Antipyretic Analgesics Sales Market Share by Type (2021-2032)
- 6.2 Global Antipyretic Analgesics Revenue by Type (2021-2032)
- 6.2.1 Global Antipyretic Analgesics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antipyretic Analgesics Revenue Market Share by Type (2021-2032)
- 6.3 Global Antipyretic Analgesics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antipyretic Analgesics Sales by Application (2021-2032)
- 7.1.1 Global Antipyretic Analgesics Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Antipyretic Analgesics Sales Market Share by Application (2021-2032)
- 7.2 Global Antipyretic Analgesics Revenue by Application (2021-2032)
- 7.2.1 Global Antipyretic Analgesics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antipyretic Analgesics Revenue Market Share by Application (2021-2032)
- 7.3 Global Antipyretic Analgesics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antipyretic Analgesics Value Chain Analysis
- 8.1.1 Antipyretic Analgesics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antipyretic Analgesics Production Mode & Process
- 8.2 Antipyretic Analgesics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antipyretic Analgesics Distributors
- 8.2.3 Antipyretic Analgesics Customers
9 Global Antipyretic Analgesics Analyzing Market Dynamics
- 9.1 Antipyretic Analgesics Industry Trends
- 9.2 Antipyretic Analgesics Industry Drivers
- 9.3 Antipyretic Analgesics Industry Opportunities and Challenges
- 9.4 Antipyretic Analgesics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst